RYN

WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) announced today that the Company's board of directors has declared a fourth quarter cash dividend of $0.26 per common share. The dividend is payable on December 31, 2026, to shareholders of record on December 17, 2026. The Company also announced today that the Company's board of directors, in its capacity as the board of directors of the general partner of Rayonier, L.P., has declared a fourth quarter cash distribution of $0.26 per oper.

Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.

Packaging company Clearwater Paper was a contributor in the quarter. Alaskan cable company Liberty Capital was a contributor in the quarter. Empire State Realty's underperformance this quarter was mostly driven by its Empire State Building Observatory hitting a rough patch over the last two years. Broadband operator Shenandoah Telecommunications was a contributor for us in the first half of the year but detracted in the third quarter.

Rayonier is rated Buy with a $23.04 target, driven by asset value and a 5.5% dividend yield, over an 18–24 month horizon. My thesis emphasizes monetization of land, merger integration, and prudent NAV adjustments, rather than relying on a lumber sector rebound. Merger integration is key; $40 million in annual synergies are a goal, not a realized benefit, with cost reduction and cash conversion as priorities.

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

The Undercovered Dozen series spotlights 12 lesser-covered stocks featured on Seeking Alpha. This curated selection aims to provide fresh investment ideas and foster community discussion around under-the-radar equities. Readers are encouraged to engage, share perspectives, and highlight additional overlooked investment opportunities.

Rayonier Inc. is rated Buy, following its transformative merger with PotlatchDeltic, which nearly doubled share count and expanded timberland and manufacturing assets. RYN now offers a 5% dividend yield, improved cash flow, and enhanced land optimization, though post-merger leverage is higher and dividend coverage remains tight. The $40 million synergy target is key for per-share value gains, with real estate and wood products diversification providing both upside and increased cyclicality.

WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) today released its 2025 Corporate Responsibility Report. The report highlights the company's progress across four corporate responsibility pillars: Forests, Planet, People, and Practices. These pillars focus on managing forests sustainably, minimizing environmental impacts, focusing on Team Members and safety, and prioritizing strong governance practices. “At Rayonier, sustainability and corporate responsibility are ingrained in everyth.

Rayonier Inc. (RYN) Q2 2026 Earnings Call Transcript

Rayonier (RYN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.